Back to search
FDAFDA · Food and drugs·Recall number D-0362-2025

Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsules bottles, Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409-0219, USA, UPC 0 41167 00670 2

Published April 23, 2025 · Recall initiated: March 26, 2025

Summary

FDA records drug Class II recall D-0362-2025, published April 23, 2025 and initiated March 26, 2025. Recalling firm: Chattem Inc; Status: Ongoing; Reported quantity: 129,240 bottles; Lot: LOT 22L603, EXP: Oct 2025; LOT 378999, EXP: Feb 2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Chattem Inc
Distributor
Nationwide.
Lot
LOT 22L603, EXP: Oct 2025; LOT 378999, EXP: Feb 2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsules bottles, Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409-0219, USA, UPC 0 41167 00670 2 recalled?

Yes. FDA published recall D-0362-2025 on April 23, 2025. Reported hazard: CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit

What should I do if I have this product?

Voluntary: Firm initiated